These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11364918)

  • 1. Adefovir dipivoxil (Preveon) expanded access begins.
    AIDS Treat News; 1997 Dec; (No 285):5-6. PubMed ID: 11364918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adefovir dipivoxil (Preveon) expanded access restrictions being eased.
    James JS
    AIDS Treat News; 1998 Feb; (No 288):4-5. PubMed ID: 11365045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adefovir dipivoxil (Preveon) improved expanded-access program.
    AIDS Treat News; 1998 Apr; (No 293):6. PubMed ID: 11365388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three drugs now in expanded access.
    Gilden D
    GMHC Treat Issues; 1997 Oct; 11(10):12. PubMed ID: 11364820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adefovir dipivoxil (Preveon) new results with hepatitis B, HIV.
    James JS
    AIDS Treat News; 1998 Apr; (No 293):6-7. PubMed ID: 11365389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preveon expanded access program broadened.
    Highleyman L
    BETA; 1998 Jul; ():3. PubMed ID: 11365558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug in expanded access.
    Vazquez E
    Posit Aware; 1998; 9(1):16. PubMed ID: 11364994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower doses of adefovir dipivoxil (Preveon).
    Res Initiat Treat Action; 1999 Apr; 5(2):34. PubMed ID: 11366287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adefovir dipivoxil trials: CD4 100-500, protease inhibitor naive.
    AIDS Treat News; 1997 Sep; (No 278):6. PubMed ID: 11364624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and hep B drug trial enrolling.
    Vazquez E
    Posit Aware; 1997; 8(5):17. PubMed ID: 11364634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanded access programs.
    Treat Rev; 1997 Nov; (No 26-27):12. PubMed ID: 11364931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adefovir dipivoxil: new preparation. A third-line option in chronic hepatitis B.
    Prescrire Int; 2004 Feb; 13(69):4-7. PubMed ID: 15055205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded access.
    Notes Undergr; 1997 Nov; (No 36):6. PubMed ID: 11365207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded access for adefovir.
    Highleyman L
    BETA; 1998 Jan; ():4. PubMed ID: 11364977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded access programs expanding.
    Proj Inf Perspect; 1997 Nov; (23):20-1. PubMed ID: 11365376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new, what's next?
    Fakuda D
    Posit Dir News; 1998; 10(2):1, 3-7, 10. PubMed ID: 11365547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney dysfunction: a safety update on adefovir (preveon).
    Baker R
    BETA; 1998 Jul; ():9-10. PubMed ID: 11365573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.